X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immunotherapy (109) 109
index medicus (100) 100
oncology (82) 82
cancer (78) 78
neoantigens (74) 74
humans (72) 72
pd-1 blockade (51) 51
immunology (49) 49
neoantigen (47) 47
mutation (45) 45
tumors (43) 43
tumor-infiltrating lymphocytes (39) 39
melanoma (38) 38
lymphocytes (36) 36
t cells (35) 35
expression (32) 32
antigens (31) 31
ctla-4 blockade (31) 31
tumor antigens (31) 31
immunotherapy - methods (27) 27
neoantigen load (27) 27
animals (26) 26
female (26) 26
neoplasms - immunology (26) 26
t-cells (26) 26
immune response (25) 25
immune checkpoint (24) 24
lymphocytes t (23) 23
antigens, neoplasm - immunology (22) 22
analysis (20) 20
care and treatment (20) 20
gene expression (20) 20
nivolumab (19) 19
checkpoint blockade (18) 18
chemotherapy (18) 18
deoxyribonucleic acid--dna (18) 18
metastasis (18) 18
patients (18) 18
landscape (17) 17
metastatic melanoma (17) 17
biomarkers (16) 16
lung cancer (16) 16
peptides (16) 16
sensitivity (16) 16
vaccines (16) 16
adult (15) 15
aged (15) 15
article (15) 15
breast cancer (15) 15
cancer vaccines (15) 15
middle aged (15) 15
mutations (15) 15
neoplasms - genetics (15) 15
neoplasms - therapy (15) 15
drug therapy (14) 14
exome analysis reveals (14) 14
immune system (14) 14
ovarian cancer (14) 14
pd-l1 (14) 14
association (13) 13
blockade (13) 13
cancer therapies (13) 13
genetic aspects (13) 13
genomics (13) 13
medical research (13) 13
review (13) 13
therapy (13) 13
cancer immunotherapy (12) 12
cell biology (12) 12
dendritic cells (12) 12
genomes (12) 12
proteins (12) 12
tumor (12) 12
apoptosis (11) 11
cancer-immunotherapy (11) 11
endometrial cancer (11) 11
genetics & heredity (11) 11
health aspects (11) 11
immunogenicity (11) 11
male (11) 11
microsatellite instability (11) 11
pd-l1 protein (11) 11
research (11) 11
somatic mutations (11) 11
antigen (10) 10
antigens, neoplasm - genetics (10) 10
antitumor immunity (10) 10
cell lung-cancer (10) 10
clinical trials (10) 10
cytotoxicity (10) 10
human-melanoma (10) 10
immune checkpoint blockade (10) 10
immune checkpoint inhibitors (10) 10
medical colleges (10) 10
medicine & public health (10) 10
metastases (10) 10
mismatch repair (10) 10
original research (10) 10
pathology (10) 10
pd-1 protein (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature Genetics, ISSN 1061-4036, 02/2019, Volume 51, Issue 2, pp. 202 - 206
Journal Article
Cytotherapy, ISSN 1465-3249, 07/2019
BACKGROUNDMedulloblastoma is the most common malignant brain tumor in childhood and adolescence. Although some patients present with distinct genetic... 
Index Medicus
Journal Article
Cell, ISSN 0092-8674, 11/2017, Volume 171, Issue 4, pp. 934 - 949.e16
Journal Article
OncoImmunology, ISSN 2162-4011, 08/2017, Volume 6, Issue 8, pp. e1338996 - e1338996
Neoantigens derived from tumor-specific somatic mutations are excellent targets for anti-tumor immune responses. In ovarian clear cell carcinoma (OCCC),... 
neoantigen | ovarian clear cell carcinoma | Immune signature | neoantigen frequency | prognostic factor | missense mutation | CTLA-4 BLOCKADE | LANDSCAPE | ANTIBODY | IMMUNOLOGY | CANCER | ONCOLOGY | RECURRENT | POOR-PROGNOSIS | EXPRESSION | T-CELLS
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2018, Volume 110, Issue 7, pp. 787 - 790
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a highly aggressive monogenic cancer driven by SMARCA4 mutations. Here, we report responses... 
TUMOR-INFILTRATING LYMPHOCYTES | INSTABLE ENDOMETRIAL CANCERS | LUNG-CANCER | NUMBER | ONCOLOGY | PD-1 BLOCKADE | SMARCA4 MUTATIONS | NEOANTIGEN LOAD | NIVOLUMAB | EXPRESSION | ASSOCIATION
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 04/2019, Volume 25, Issue 8, pp. 2537 - 2548
Purpose: Tumors with high mutation load are thought to engender stronger immune responses, which in turn promote prolonged patient survival. To investigate... 
TUMOR-INFILTRATING LYMPHOCYTES | T-CELL RESPONSES | PEMBROLIZUMAB | ONCOLOGY | PROGNOSIS | PD-1 BLOCKADE | INDOLEAMINE 2,3-DIOXYGENASE | MISMATCH REPAIR-DEFICIENT | MUTATIONAL LANDSCAPE | NEOANTIGEN LOAD | CANCER | Index Medicus
Journal Article
GENE, ISSN 0378-1119, 03/2018, Volume 647, pp. 31 - 38
Mutations in the exonuclease domain of polymerase epsilon (POLE), an enzyme of DNA synthesis, are involved in a newly described syndrome of colorectal... 
MISMATCH-REPAIR DEFICIENCY | LANDSCAPE | MICROSATELLITE INSTABILITY | PD-1 BLOCKADE | NEOANTIGEN LOAD | ENDOMETRIAL CANCERS | TUMOR-INFILTRATING LYMPHOCYTES | Polymerase epsilon | GENOMICS | GENETICS & HEREDITY | cBioportal | Exonuclease domain | EXPRESSION | Neo-antigens | Genomic
Journal Article
Neurosurgery, ISSN 0148-396X, 06/2019, Volume 84, Issue 6, pp. E318 - E333
BACKGROUND Currently, clinical implications of immune system cells in chordoma remain to be elucidated. OBJECTIVE To characterize in situ immune cell... 
SURVIVAL | SURGERY | CELLS | Biomarker | Tumor-infiltrating lymphocytes | Immunoscore | PD-L1 EXPRESSION | Tumor immune microenvironment | PHASE-II | NEOANTIGEN LOAD | CANCER | CLINICAL NEUROLOGY | Spinal chordoma | GROWTH | Prognostic factor | RECURRENCE | PD-1 | ASSOCIATION | PD-L1 axis
Journal Article
OncoImmunology, ISSN 2162-4011, 02/2017, Volume 6, Issue 2, pp. e1277308 - e1277308
Clear cell ovarian carcinoma (CCOC) represents a distinct histologic subtype of ovarian cancer associated with significantly worse prognosis across all stages... 
PD-L1 | microsatellite instability | tumor-infiltrating lymphocytes | PD-1 | Clear cell ovarian cancer | immunotherapy | NUMBER | ONCOLOGY | NEOANTIGEN LOAD | IMMUNOLOGY | ASSOCIATION
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1751 - 11
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2018, Volume 118, Issue 7, pp. 933 - 935
Journal Article